Last Updated On 4/21/2025 10:04:09 AM
This is a disclosure report of the user financial relationships with for-profit health care companies.
All relationships are considered compensated unless otherwise noted. Relationships are self-held unless otherwise noted.
Employment |
No Relationships to Disclose |
|
|
Leadership |
No Relationships to Disclose |
|
|
Stock and Other Ownership Interests |
No Relationships to Disclose |
|
|
Honoraria |
No Relationships to Disclose |
|
|
Consulting or Advisory Role |
Company: Kite, a Gilead company |
Recipient: You |
Company: Genmab/Abbvie |
Recipient: You |
Company: Pierre Fabre |
Recipient: You |
|
Speakers' Bureau |
Company: Research to Practice |
Recipient: You |
|
Research Funding |
Company: Sanofi |
Recipient: Your Institution |
Company: Forty Seven |
Recipient: Your Institution |
Company: Celene |
Recipient: Your Institution |
Company: Seattle Genetics |
Recipient: Your Institution |
|
Patents, Royalties, Other Intellectual Property |
Please describe: Up to Date royalties |
Recipient: You |
|
Expert Testimony |
No Relationships to Disclose |
|
|
Travel, Accommodations, Expenses |
No Relationships to Disclose |
|
|
Other Relationship |
No Relationships to Disclose |
|
|
(OPTIONAL) Uncompensated Relationships |
not answered |
|
|
(OPTIONAL) Open Payments Link |
not answered |
|
|